-
Dr. Justin Oveyssi is an Assistant Clinical Professor of Medicine in Transplant Nephrology at UCSF. His clinical and academic work focuses on post–kidney transplant care, including immune-mediated complications and long-term outcomes in transplant recipients. He is passionate about improving care coordination and long-term follow-up for living kidney donors and transplant patients. Living kidney donors are often described as heroes. They are individuals who voluntarily accept surgical and [...]
-
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from the July 2026 issue: Prevalence of CKD Among Adults in Africa: A Systematic Review and Meta-Analysis by Cindy George et al. [OPEN [...]
-
So many eminently qualified applicants responded to our recent call for applications to the AJKD Editorial Internship Program, the editors were both impressed, and saddened that they could only pick 5. Please join us in welcoming our ninth class, the 2026-27 AJKD Editorial Interns: Natalie Hobeika, Patrick Hofmann, Michael Reaume, Amara Sarwal, and Emily K. Yeung. Natalie Hobeika Natalie Hobeika is a current nephrology fellow at Northwestern University in Chicago, Illinois. Born and [...]
-
Atrial fibrillation is common among patients with kidney failure treated with hemodialysis. A recent study published in AJKD by Winkelmayer et al examined the efficacy and safety of apixaban for atrial fibrillation in patients on dialysis. AJKDBlog’s Interviews Editor Timothy Yau chatted with author Wolfgang C. Winkelmayer about the clinical conundrum of both increased stroke and increased bleeding risk in patients on dialysis and how this affects the decision to anticoagulate. They review [...]
-
NephMadness 2026 is still fresh in our memories, but it’s already time to start thinking about NephMadness 2027! Which topics would you like to see in next year’s edition of the madness? Last year you demanded more Animal House (and we were happy to oblige): And this suggestion from 2024 came to fruition: Want to see your name in next year’s post? Then leave a comment with your ideas for NephMadness 2027, or post them on the social media platform of your choice with the [...]
Follow Blog by Email:
NephMadness 2026
-
NephMadness#NephMadness 2026: The Left and Right Kidneys
-
NephMadness#NephMadness 2026: Meet the Gamemakers
-
NephMadness#NephMadness 2026: IgA Nephropathy – The Bench is Loaded, but is There a Clear Star?
-
NephMadness#NephMadness 2026: C3G Treatment–The Ultimate Glow-Up Story
-
NephMadness#NephMadness 2026: The Winners
-
NephMadness#NephMadness 2026: The Effluent Eight
-
NephMadness#NephMadness 2026: The PodCrawl
-
NephMadness#NephMadness 2026: A future so bright you gotta wear shades – B-cell modulating therapies in IgAN
Atlas of Renal Pathology II
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology: Light Chain Cast Nephropathy
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: An Approach to Pathologic Assessment
-
Atlas of Renal Pathology IIRecurrent and De Novo FSGS Following Kidney Transplantation
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 1
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology II: The Ultimate Pathology Teaching Tool Has Arrived
-
Atlas of Renal Pathology IIDiffuse Mesangial Sclerosis
-
Atlas of Renal Pathology IICongenital Nephrotic Syndrome: Finnish Type or Diffuse Mesangial Sclerosis?
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: Sampling Error in Misdiagnosis
-
Atlas of Renal Pathology IIRecurrent and De novo Posttransplant Minimal Change Disease
-
Atlas of Renal Pathology IIPractical Tips for the Diagnosis of Acute Antibody-Mediated Rejection
Follow Blog by Email:
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy







